GRIFOLS reported €397.86M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alcon AG ALC:SW 961M 614M
Amadeus IT AMS:SM € 722.1M 405.6M
Amarin AMRN:US $ 219.15M 0.3M
Artemis Alpha ATS:LN 7.15M 672K
AstraZeneca AZN:LN 5762M 567M
Bayer BAYN:GR € 5785M 1221M
Fresenius FRE:GR € 2077M 1146M
Fresenius Medical Care FME:GR € 1173.34M 616.82M
Genmab GEN:DC DK 9071M 114M
GlaxoSmithKline GSK:LN 10967M 6693M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 22M 20M
Inditex ITX:SM € 6589M 432M
Merck MRK:GR € 1339M 560M
Novartis NOVN:VX SF 13852M 1445M
Philips PHIA:NA € 1445M 858M